Title: www.pharmacyreturns.com - Newsletter
![]() ![]()
|
|
Your trial of the PharmacyReturns.com Newsletter is about to end.
SUBSCRIBE for free to avoid being bumped from our list!
|
Industry News
New Ingredients Added to Infant Formulas
Striving to create a formula that results in similar development of breast-fed babies Ross Products Division, Abbott Laboratories, announced the release of its new infant formula, Similac Advance. Ross was following the lead of Mead more...
The DEA Resumes Regular Mail Service
Due to the anthrax exposure in the Washington D.C. area all mail deliveries to DEA Headquarters in Washington D.C, were stopped. The DEA announced March 4th more...
Product Safety Alerts 2002
The FDA has developed the MedWatch program to monitor medical products once they have entered the consumer market. The goals of the Med Watch program are to clarify what should and should not be reported to FDA, to increase awareness more...
|
Tips for getting your pharmacy online!
· Choosing a Web Developer
Previously:
· What Legal Issues are there for Internet Pharmacies?
· Choosing the Type of Web Site that You Want
· Should you be VIPPS Certified?
|
Recall
Alert
Our Recalled Products section contains all the information that your pharmacy needs to identify the recalled products you may have in your inventory.
You do not need to be registered to use this portion of PharmacyReturns.com, just click the link above.
The most recently recalled products include:
D-105-2 Marinol (Dronabinol) Capsules, 2.5 mg
D-106-2 Marinol (Dronabinol) Capsules, 10 mg
D-191-2 Metoclopramide Oral Solution, USP, 5 mg/5 mL
D-192-2 Metoclopramide Oral Solution, USP, 10 mg/10 mL
D-193-2 Lunelle Monthly Contraceptive Injection, 25 mg/5mg
D-194-2 Depo-Provera Contraceptive Injection, 150 mg/ml
D-195-2 Tegretol Tablets, 200 mg
|
FDA
Drug Approvals and Applications
New prescription drug approvals are found in the following categories:
Approvable
Original New Drug Applications
02/08/2002 - CLARINEX, SCHERING
02/01/2002 - SUSTIVA , BRISTOL MYERS SQUIBB PHARMA CO
Efficacy
Supplemental New Drug Applications
02/08/2002 - ACULAR PRESERVATIVE FREE , ALLERGAN INC
02/07/2002 - FOLLISTIM, ORGANON INC SUB AKZONA INC
Labeling
Supplements to Original New Drug Applications
Original
Abbreviated and 505(b)(2) New Drug Applications with Tentative Approval
02/08/2002 - QUINAPRIL HCL, TEVA PHARMACEUTICALS USA INC
02/05/2002 - LISINOPRIL, WATSON LABORATORIES INC
Original
Abbreviated New Drug Applications
02/15/2002 - FLUOXETINE, RANBAXY LABORATORIES LIMITED
02/07/2002 - FLUOXETINE HCL, NOVEX PHARMA
Original
New Drug Applications
|
|
Your ad could be here!
Request more information to Advertise Electronically.
|
Visit the Career Center
The largest collection of pharmacy career links on the web.
Links to sites offering information on continuing education.
|
|
Learn More about PharmacyReturns.com
|
Take a Free Tour
See all the features of PharmacyReturns.com before registering.
DEMO!
|
How will I be charged for this service?
Visit the Fees
and Billing section in About
Us
|
Have you been asked to visit one of
our microsites?
If you have been asked
to authenticate your company's data take your AIN to the applicable site and receive a gift!
Policy
Microsite
Product
Microsite
|
Customer Support
Please visit our Help Section.
Send an electronic question to HELP!.
Please call toll free 1-866-525-8409 for assistance.
|
Subscription Information
If you have received this newsletter from another source, please subscribe.
To end your subscription to this newsletter unsubscribe.
|
|
